GoodRx Holdings, Inc. (GDRX)
GoodRx Holdings, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
GoodRx Holdings, Inc. (GDRX) is a Medical - Healthcare Information Services company based in US with a market capitalization of $1B. Revenue grew 0.6% year-over-year and the company generated $164.4M in free cash flow. This page tracks GDRX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 738 employees · IPO Sep 23, 2020
Valuation
Valuation & price
$2.43 · as of May 17, 2026 · -52.5% vs 52w high
28.5
P/E ratio
Latest-FY diluted EPS
1.68
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$1B
Market cap
0.6%
Revenue growth (YoY)
92.8%
Gross margin
$164.4M
Free cash flow (USD)
-$202.3M
Net debt
Net cash position
-7.6%
Share dilution
3/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2018 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 6, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is GoodRx Holdings, Inc.'s market cap?
GoodRx Holdings, Inc. (GDRX) has a market capitalization of $1B.
What is GDRX's P/E ratio?
GDRX trades at a price-to-earnings ratio of 28.5, based on its latest fiscal-year diluted earnings per share and the most recent cached price.
What is GDRX's price-to-book (P/B) ratio?
GDRX trades at 1.68 times book value per share.
Are insiders buying GDRX stock?
SEC Form 4 filings show no open-market insider buys at GoodRx Holdings, Inc. in the last 90 days (0 sells).
Same arena
Related companies in Medical - Healthcare Information Services
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.